LV10100A - Purine nucleoside phosphorylase inhibitors and their uptake - Google Patents

Purine nucleoside phosphorylase inhibitors and their uptake

Info

Publication number
LV10100A
LV10100A LV930342A LV930342A LV10100A LV 10100 A LV10100 A LV 10100A LV 930342 A LV930342 A LV 930342A LV 930342 A LV930342 A LV 930342A LV 10100 A LV10100 A LV 10100A
Authority
LV
Latvia
Prior art keywords
uptake
purine nucleoside
nucleoside phosphorylase
phosphorylase inhibitors
inhibitors
Prior art date
Application number
LV930342A
Other languages
Latvian (lv)
Other versions
LV10100B (en
Inventor
Secrist John A Iii
Mark David Erion
John A Montgomery
Steven E Ealick
Wayne C Guida
Shri Niwas
Original Assignee
Biocryst Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/429,099 external-priority patent/US5008265A/en
Priority claimed from US07/429,097 external-priority patent/US5008270A/en
Priority claimed from US07/429,098 external-priority patent/US4985434A/en
Priority claimed from US07/429,100 external-priority patent/US4985433A/en
Application filed by Biocryst Pharm Inc filed Critical Biocryst Pharm Inc
Publication of LV10100A publication Critical patent/LV10100A/en
Publication of LV10100B publication Critical patent/LV10100B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
    • C07C255/31—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing rings other than six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
    • C07C255/32—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring
    • C07C255/35—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring the carbon skeleton being further substituted by halogen atoms, or by nitro or nitroso groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
    • C07C255/32—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring
    • C07C255/40—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring the carbon skeleton being further substituted by doubly-bound oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
    • C07C255/32—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring
    • C07C255/42—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring the carbon skeleton being further substituted by singly-bound nitrogen atoms, not being further bound to other hetero atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
LVP-93-342A 1989-10-31 1993-05-14 Inhibitors of purine nucleoside phosphorylase LV10100B (en)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US07/429,099 US5008265A (en) 1989-10-31 1989-10-31 2-amino-7-(alicyclomethyl)-3H,5H,-pyrrolo[3,2-d]pyrimidin-4-ones and pharmaceutical uses and compositions containing the same
US07/429,097 US5008270A (en) 1989-10-31 1989-10-31 2-amino-7-(heterocyclomethyl)-3H,5H-pyrrolo[3,2-d]pyrimidin-4-ones and pharmaceutical uses and compositions containing the same
US07/429,098 US4985434A (en) 1989-10-31 1989-10-31 7-substituted derivatives of 2-amino-3H,5H-pyrrolo(3,2-d)pyrimidin-4-ones and pharamceutical uses and compositions containing the same
US07/429,100 US4985433A (en) 1989-10-31 1989-10-31 2-amino-7-(pyridinylmethyl)-3H,5H-pyrrolo[3,2-d]pyrimidin-4-ones and pharmaceutical uses and compositions containing the same
US44279889A 1989-11-29 1989-11-29
PCT/US1990/005756 WO1991006548A1 (en) 1989-10-31 1990-10-12 Inhibitors of purine nucleoside phosphorylase

Publications (2)

Publication Number Publication Date
LV10100A true LV10100A (en) 1994-05-10
LV10100B LV10100B (en) 1995-08-20

Family

ID=27541578

Family Applications (1)

Application Number Title Priority Date Filing Date
LVP-93-342A LV10100B (en) 1989-10-31 1993-05-14 Inhibitors of purine nucleoside phosphorylase

Country Status (9)

Country Link
EP (1) EP0500653A4 (en)
JP (1) JP2866478B2 (en)
AU (1) AU654264B2 (en)
CA (1) CA2072123C (en)
FI (1) FI103972B1 (en)
HU (1) HUT61765A (en)
LV (1) LV10100B (en)
NO (1) NO301423B1 (en)
WO (1) WO1991006548A1 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5726311A (en) * 1989-11-29 1998-03-10 Biocryst Pharmaceuticals, Inc. 7-disubstituted-methyl-4-oxo-3H,5H-pyrrolo 3,2-d!pyrimidine and pharmaceutical uses and compositions containing the same
US5236926A (en) * 1992-02-03 1993-08-17 Warner-Lambert Company 9-substituted-8-halo or -8-hydroxy-9-deazaguanines as inhibitors or PNP for pharmaceutical compositions
JPH07507062A (en) * 1992-04-21 1995-08-03 バイオクリスト・ファーマシューティカルズ・インコーポレイテッド 7-Disubstituted-methyl-4-oxo-3H,5H-pyrrolo[3,2-d]pyrimidine and pharmaceutical uses and compositions containing the same
AU695032B2 (en) * 1994-10-05 1998-08-06 Darwin Discovery Limited Purine and guanine compounds as inhibitors of PNP
GB9520364D0 (en) * 1995-10-05 1995-12-06 Chiroscience Ltd Compouundds
GB9520363D0 (en) * 1995-10-05 1995-12-06 Chiroscience Ltd Compounds
AU8210798A (en) * 1997-05-29 1998-12-30 Novartis Ag 2-amino-7-(1-substituted-2-hydroxyethyl)-3,5-dihydro-pyrrolo (3,2-d)pyrimidin-4-ones
US6174888B1 (en) 1998-05-28 2001-01-16 Novartis Ag 2-amino-7-(1-substituted-2-hydroxyethyl)-3,5-dihydropyrrolo[3,2-D]pyrimidin-4-ones
JP4496586B2 (en) * 2000-01-24 2010-07-07 日産化学工業株式会社 Process for producing quinolylacrylonitrile and its intermediate
ATE505474T1 (en) * 2002-08-21 2011-04-15 Einstein Coll Med INHIBITORS OF NUCLEOSIDE PHOSPHORYLASES AND NUCLEOSIDASES
NZ523970A (en) * 2003-02-04 2005-02-25 Ind Res Ltd Process for preparing inhibitors of nucleoside phoshorylases and nucleosidases
EP2225226B1 (en) 2007-12-26 2016-08-17 Critical Outcome Technologies, Inc. Compounds and their use in a method for treatment of cancer
EP2318406B1 (en) 2008-07-17 2016-01-27 Critical Outcome Technologies, Inc. Thiosemicarbazone inhibitor compounds and cancer treatment methods
EP3235818A3 (en) 2010-04-01 2018-03-14 Critical Outcome Technologies, Inc. Compounds for the treatment of hiv

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5988484A (en) * 1982-11-09 1984-05-22 Takeda Chem Ind Ltd Novel 7-deazapurine derivative
CA1293727C (en) * 1986-08-26 1991-12-31 Catherine Rose Kostlan 9-deazaguanines
US4921858A (en) * 1986-10-24 1990-05-01 Warner-Lambert Company 7-deazaguanines as immunomodulators
CA1294960C (en) * 1986-10-24 1992-01-28 Thomas C. Malone 7-deazaguanines as immunomodulators
DE3726044A1 (en) * 1987-02-11 1988-08-25 Bayer Ag ACARICIDES ON THE BASIS OF AZOMETHINE DERIVATIVES AND AZOMETHINE OF 2,3-DIAMINOMALEAINSAURENITRILE
US4927830A (en) * 1988-04-08 1990-05-22 The Regents Of The University Of Michigan Acyclic pyrrolo[2,3-D]pyrimidine analogs as antiviral agents
WO1990010631A1 (en) * 1989-02-27 1990-09-20 Biocryst 9-substituted-8-unsubstituted-9-deazaguanines
US4985433A (en) * 1989-10-31 1991-01-15 Biocryst, Inc. 2-amino-7-(pyridinylmethyl)-3H,5H-pyrrolo[3,2-d]pyrimidin-4-ones and pharmaceutical uses and compositions containing the same
US4985434A (en) * 1989-10-31 1991-01-15 Biocryst, Inc. 7-substituted derivatives of 2-amino-3H,5H-pyrrolo(3,2-d)pyrimidin-4-ones and pharamceutical uses and compositions containing the same

Also Published As

Publication number Publication date
NO921679D0 (en) 1992-04-29
FI103972B (en) 1999-10-29
HU9201450D0 (en) 1992-09-28
JP2866478B2 (en) 1999-03-08
FI921900A0 (en) 1992-04-28
NO921679L (en) 1992-06-17
EP0500653A4 (en) 1995-08-23
FI103972B1 (en) 1999-10-29
HUT61765A (en) 1993-03-01
FI921900A (en) 1992-04-28
AU6712590A (en) 1991-05-31
CA2072123C (en) 2001-06-12
NO301423B1 (en) 1997-10-27
AU654264B2 (en) 1994-11-03
CA2072123A1 (en) 1991-05-01
EP0500653A1 (en) 1992-09-02
JPH05504551A (en) 1993-07-15
LV10100B (en) 1995-08-20
WO1991006548A1 (en) 1991-05-16

Similar Documents

Publication Publication Date Title
LV5781A4 (en) Healing Nucleoside
DE19575021I2 (en) Therapeutic nucleosides
DK713488D0 (en) adenosine
DE69033197T2 (en) Therapeutic nucleosides
NO2001013I2 (en) capecitabine
EP0219829A3 (en) 2-fluoro-arabinofuranosyl purine nucleosides
LV10100A (en) Purine nucleoside phosphorylase inhibitors and their uptake
DK23489D0 (en) nucleoside
DK375989A (en) purine derivatives
DK564088A (en) nucleoside
DK630589A (en) 2 ', 3'-DIDEOXYPURINNUCLEOSID / purine nucleoside phosphorylase inhibitor COMPOSITION
BR8807225A (en) INCREASED LEVEL OF 2-METHYL-2-BUTENE IN ISOAMYLENE
DK406689A (en) THERAPEUTIC NUCLEOSIDES
DK626989A (en) adenosine
DK95791A (en) nucleoside analogues
DK339189D0 (en) purine derivatives
BR6601850U (en) IMITATION OF MONKEY MADE IN ACRYLIC PELUCIA
BR6700623U (en) PROVISION INTRODUCED IN IMPULSE ABSORBOR
BR6901794U (en) PROVISION INTRODUCED IN BULLET HOLDER
IE900125L (en) Purine nucleosides and nucleotides
BR6900084U (en) PROVISION INTRODUCED IN IGNITION INHIBITOR
NO921776L (en) Nucleoside derivative
BR6901141U (en) PROVISION INTRODUCED IN DART GAME
ATE104675T1 (en) THERAPEUTIC NUCLEOSIDES.
BR6900662U (en) ARRAY INTRODUCED IN BATON HOLDER